COMPASS THERAPEUTICS, INC. Accounts Payable
COMPASS THERAPEUTICS, INC. (CMPX) had Accounts Payable of $2.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $2.91M.
- 2026-03-31: Accounts Payable, Current $906.00K.
- 2025-12-31: Accounts Payable, Current $1.58M.
- 2025-09-30: Accounts Payable, Current $3.10M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $906.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.58M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $3.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.25M 10-K · filed 2026-03-05 |
| 2024-09-30 | $960.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.19M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $854.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $4.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.31M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $724.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.13M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.38M 10-K · filed 2024-03-21 |
| 2022-09-30 | $2.76M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.53M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $257.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $867.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $868.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $559.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.06M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $1.06M 10-K · filed 2022-03-18 |
| 2020-09-30 | $854.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.58M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $629.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |